HIT Stock Risk & Deep Value Analysis
Health In Tech Inc
Technology • Software - Application
DVR Score
out of 10
What You Need to Know About HIT Stock
We analyzed Health In Tech Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran HIT through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
HIT Risk Analysis & Red Flags
What Could Go Wrong
The company relies heavily on securing major enterprise contracts and scaling its enrolled employee base. If customer acquisition costs rise significantly or sales cycles are prolonged, HIT could face further cash burn beyond its current runway, necessitating more dilutive capital raises that could depress share price despite revenue growth.
Risk Matrix
Overall
Aggressive
Financial
Medium
Market
Medium
Competitive
High
Execution
High
Regulatory
Medium
Red Flags
- ⚠
Q4 2025 showed a net loss increase and Adjusted EBITDA decrease compared to prior Q4, indicating potential seasonality or higher operational costs.
- ⚠
Lack of detailed segment breakdown makes it difficult to assess specific product/service performance.
- ⚠
Significant dilution risk from future capital raises given small market cap and growth ambitions.
Upcoming Risk Events
- 📅
Slower-than-expected client acquisition or contract delays
- 📅
Higher-than-anticipated cash burn in Q1/Q2 2026 leading to further dilution
- 📅
Increased competitive pressure from larger digital health players
When to Reconsider
- 🚪
Exit if full-year revenue growth decelerates below 40% for two consecutive years.
- 🚪
Sell if cash balance drops below $5 million without clear funding prospects.
- 🚪
Exit if gross margins compress significantly below 50% for two consecutive quarters.
Unlock HIT Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does Health In Tech Inc (HIT) Do?
Market Cap
$82.19M
Sector
Technology
Industry
Software - Application
Employees
73
Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
Visit Health In Tech Inc WebsiteInvestment Thesis
Health In Tech is a high-growth, small-cap company leveraging AI to disrupt the healthcare industry with personalized preventive care. Its recent achievement of full-year profitability, coupled with strong revenue growth and a strengthened balance sheet, positions it favorably for significant market share capture within the vast digital health market. Future enterprise contracts and clinical validation could drive substantial re-rating and 10x growth within 3-5 years.
Is HIT Stock Undervalued?
Unlock the full AI analysis for HIT
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
HIT Price Targets & Strategy
12-Month Target
$4.00
Bull Case
$6.00
Bear Case
$2.00
Valuation Basis
Based on 5x forward P/S applied to estimated FY26 revenue of $52M
Entry Strategy
Dollar-cost average between $1.30-$1.60, targeting accumulation on any market dips, given the stock's early stage and volatility potential.
Exit Strategy
Consider taking initial profits at $4.00, reassess at $6.00. Implement a trailing stop-loss below the 50-day moving average or at $1.20 to protect capital.
Portfolio Allocation
5% for moderate risk tolerance
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Is HIT Financially Healthy?
Valuation
P/E Ratio
64.27
Price/Book
5.52
Price/Sales
2.83
Profitability
Gross Margin
62.82%
Operating Margin
4.59%
Net Margin
3.84%
Return on Equity
7.89%
Revenue Growth
70.99%
EPS
$0.02
Balance Sheet
Current Ratio
3.13
Quick Ratio
2.50
Cash & Equivalents
$7.70M
Cash Flow
EBITDA
$4.10M
Other
Beta (Volatility)
0.15
Does HIT Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Expanding
Moat Sources
3 Identified
The moat is strengthening as HIT accumulates more health data, refines its AI models, and integrates deeper into employer benefit ecosystems, increasing the switching costs for clients. However, new entrants with superior AI or large incumbents could erode this over time.
Moat Erosion Risks
- •Failure to continuously innovate AI algorithms and data analysis tools.
- •Emergence of a dominant, comprehensive digital health platform offering similar services.
- •Data privacy concerns or breaches leading to loss of trust and regulatory fines.
HIT Competitive Moat Analysis
Sign up to see competitive advantages
HIT Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral. Limited specific data available, but digital health generally garners interest.
Institutional Sentiment
Neutral. No analyst coverage or institutional ownership percentages reported in the immediate research. The PIPE indicates some institutional/private investor confidence.
Insider Activity (Form 4)
No Form 4 filings reported for last 90 days (Jan 18-Apr 18, 2026). No CEO/CFO activity flagged.
Options Flow
Normal options activity. No unusual activity flagged from live sources.
Earnings Intelligence
Next Earnings
Estimated late May / early June 2026 (for Q1 2026)
Surprise Probability
Medium
Historical Earnings Pattern
Insufficient historical data provided to establish a consistent pattern. Given its small cap and growth stage, expect high volatility post-earnings.
Key Metrics to Watch
Competitive Position
Top Competitor
TELADOC (TDOC) / LIVONGO (part of TDOC)
Market Share Trend
Gaining. Small base allows for significant percentage growth, capturing niche market share in personalized preventive care segment.
Valuation vs Peers
Trading at a discount on a P/S basis (2.95x FY25 P/S) compared to larger, established digital health peers which often trade at 4-8x P/S for similar growth rates, indicating potential for multiple expansion if execution continues.
Competitive Advantages
- •AI-driven personalized preventive care model targeting long-term health outcomes.
- •Developing a proprietary data moat from enrolled employee engagement.
- •Focus on employer-based contracts provides scalable distribution channel.
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive HIT Stock Higher?
Near-Term (0-6 months)
- •Major enterprise contract announcements (Q2-Q4 2026)
- •Continued growth in billed enrolled employees (Q2 2026 earnings report)
- •Progress on clinical validation studies for platform efficacy (H2 2026)
Medium-Term (6-18 months)
- •Strategic partnerships with healthcare providers or insurers (2027)
- •Expansion into new geographic markets (2027-2028)
- •Enhancements to AI platform functionality and data integration (Ongoing)
Long-Term (18+ months)
- •Disruption of traditional employer-sponsored healthcare models (2028+)
- •Dominant market share in AI-driven personalized preventive care (2029+)
- •Deepening of proprietary data moat and predictive analytics capabilities (Ongoing)
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for HIT?
- ✓
Acceleration in billed enrolled employee growth rates QoQ
- ✓
Announcement of significant new enterprise clients or partnerships
- ✓
Consistent positive net income and free cash flow generation for subsequent quarters
Bull Case Analysis
See what could go right with Premium
Competing with HIT
See how Health In Tech Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
Health In Tech Inc HIT | $82.2M | 8.4 | 64.3 | $33.3M | 3.8% | 71.0% | |
Apple Inc AAPL | $3.9T | 1.5 | 33.2 | $391.0B | 27.0% | 10.1% | Compare → |
Alphabet Inc GOOGL | $4.2T | 1.0 | 31.5 | $402.8B | 32.8% | 15.1% | Compare → |
Meta Platforms Inc META | — | 5.1 | 15.7 | — | 30.1% | 22.2% | Compare → |
Microsoft Corp MSFT | — | 0.5 | — | — | — | — | Compare → |
NVIDIA Corp NVDA | $4.4T | 5.3 | 38.5 | $215.9B | 55.6% | 65.0% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
How Health In Tech Inc Makes Money
Health In Tech (HIT) operates an AI-driven digital health platform that offers personalized preventive care solutions. The company partners primarily with employers to provide their employees with customized health programs, tools, and insights aimed at improving long-term health outcomes and reducing healthcare costs. This subscription-based model allows employers to offer cutting-edge health benefits to their workforce while creating a scalable revenue stream for HIT.
Read Full Business Model BreakdownFAQ
What is the DVR Score for Health In Tech Inc (HIT)?
As of April 18, 2026, Health In Tech Inc has a DVR Score of 8.4 out of 10, placing it in the "Hidden Gem" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Health In Tech Inc?
Health In Tech Inc's market capitalization is approximately $82.2M. The company operates in the Technology sector within the Software - Application industry.
What ticker symbol does Health In Tech Inc use?
HIT is the ticker symbol for Health In Tech Inc. The company trades on the NCM.
What is the risk level for HIT stock?
Our analysis rates Health In Tech Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of HIT?
Health In Tech Inc currently has a price-to-earnings (P/E) ratio of 64.3. This is above the market average, suggesting the stock may be priced for high growth expectations.
Is Health In Tech Inc's revenue growing?
Health In Tech Inc has reported revenue growth of 71.0%. The company is showing strong top-line momentum.
Is HIT stock profitable?
Health In Tech Inc has a profit margin of 3.8%. The company is profitable but margins are modest.
How often is the HIT DVR analysis updated?
Our AI-powered analysis of Health In Tech Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on April 18, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for HIT (Health In Tech Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.